Plus Biomedicals designs and manufactures biomedical devices for neurorehabilitation, offering the MoveON® range of products that use proprioceptive stimuli, balance recovery, and sensorized braces to support physical recovery. The company also provides feasibility analysis and product validation services for external biomedical ideas, leveraging its expertise in device development.
Funding
Funding not disclosed
Founders
Product
Problem
Patients undergoing neurorehabilitation often face slow or incomplete recovery due to limited access to devices that effectively stimulate proprioceptive pathways and support motor function restoration. Traditional rehabilitation tools may not adequately address balance, muscle recruitment, or sensory feedback, hindering progress after neurological events, traumas, or surgeries.
Solution
Plus Biomedicals provides a range of biomedical devices under the MoveON® brand to enhance neurorehabilitation outcomes. The MoveON® NEUROLOGIC device delivers proprioceptive stimuli to improve quality of life, while the MoveON® ORTHOPEDIC system focuses on restoring balance and muscle recruitment capacity after injuries or operations. Additionally, the MoveON® SENSE line incorporates nanotechnology into sensorized braces, enabling comfortable and effective physical recovery. Beyond its product portfolio, the company offers analysis and feasibility services to help validate new biomedical product ideas.
Target Audience
Primary customers are healthcare professionals, rehabilitation centers, and biomedical product developers seeking advanced neurorehabilitation devices or support in validating new medical device concepts.
Features
- MoveON® NEUROLOGIC: uses proprioceptive stimuli to support neurorehabilitation and enhance patient quality of life
- MoveON® ORTHOPEDIC: targets recovery of balance and muscle recruitment following trauma or surgical procedures
- MoveON® SENSE: integrates nanotechnology into sensorized braces for comfortable, sensor-driven rehabilitation support
- Product validation services: provides analysis and feasibility assessments for external biomedical product concepts